Most common adverse reactions (≥ 20%) are fatigue, musculoskeletal pain, diarrhea, COVID-19, bruising, and cough. Grade 3 or 4 laboratory abnormalities (≥ 10%) are neutrophil count decreased, platelet count decreased, hemoglobin decreased, and lymphocyte count decreased.
from FDA,2024.06
During treatment with pirtobrutinib, some side effects may occur, and these effe···【more】
Release date:2026-03-25Recommended:53